Effective measures for the secondary prevention of TTP include: prevention any further clinically significant allergic or anaphylactic reactions and facilitated both patients’ TTP (inherited and acquired<unk><unk>  purpura) remissions.
Thrombotic thrombocytopenic purpura secondary prevention
Heparin-induced thrombocytopenia future or investigational therapies
Heparin-induced thrombocytopenia primary prevention
Thrombotic thrombocytopenic purpura medical therapy
Glanzmann's thrombasthenia medical therapy
Heparin-induced thrombocytopenia medical therapy
Essential thrombocytosis secondary prevention
Glanzmann's thrombasthenia future or investigational therapies